Scrutinize the data and tweets to envisage if the closing price of $bmy will swell or contract at 2017-02-17. Please affirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-03,-0.4,0.3,-0.8,0.6,0.6,-2.2,-3.2,0.4,4.2,6.6,8.0
2017-02-06,-0.8,0.1,-0.9,0.5,0.5,-1.7,-3.5,-0.8,2.8,5.4,7.0
2017-02-07,-0.3,1.3,-0.8,1.2,1.2,-1.9,-4.1,-2.6,0.7,3.7,5.3
2017-02-08,-1.4,0.2,-1.7,0.7,0.7,-1.5,-4.3,-3.7,-0.7,2.4,4.1
2017-02-09,1.0,1.4,-0.1,-0.9,-0.9,-0.2,-2.5,-3.3,-0.3,2.8,4.6
2017-02-10,-0.1,0.6,-0.3,0.3,0.3,-0.2,-2.0,-3.3,-1.0,1.9,3.9
2017-02-13,-0.4,0.1,-0.8,0.7,0.7,-0.5,-2.1,-3.7,-2.1,0.5,2.8
2017-02-14,-2.6,1.0,-3.0,3.2,3.2,-2.8,-4.3,-6.1,-5.4,-3.1,-0.7
2017-02-15,-2.4,0.6,-2.6,2.5,2.5,-4.1,-5.5,-7.7,-7.8,-5.7,-3.3
2017-02-16,1.5,1.6,-0.7,-1.4,-1.4,-1.7,-3.5,-5.5,-6.6,-4.6,-2.3

2017-02-03: bristol-myers squibb company forecasted to earn fy2018 earnings of $3.29 per share $bmy |bristol-myers squibb company forecasted to earn fy2018 earnings of $3.29 per share $bmy |is now a good time to 
2017-02-06: rt AT_USER clinical characteristics, healthcare costs &amp; resource utilization in #hcv vary by genotype¡ú #hepc #¡­|rt AT_USER $bmy jana partners report new stake|$bmy bristol-myers partner innate c
2017-02-07:  alerted another winner. must see track record &amp; subscribe  $jah $clr $dis $mo $bmy $pot| members have an advantage. see track record &amp; join  $dow $jah $clr $dis $mo $bmy|long term value plays
2017-02-08: eagle global advisors llc has $232,000 position in bristol-myers squibb company $bmy |bristol-myers squibb company $bmy position maintained by commonwealth bank of australia |fy2017 eps estimates for 
2017-02-09: 3-6 week outlook - short $dis long $bmy $tlt $twtr and expect a 5-8% correction in all major indicies. rates seem stable, wanna buy a house?|man...i've been wanting to do something in $bmy, but the st
2017-02-10: bristol-myers squibb company¡¯s $bmy buy rating reaffirmed at gabelli |bristol-myers squibb company¡¯s $bmy buy rating reaffirmed at gabelli |AT_USER AT_USER russ plumb's last co a littleknown antivir
2017-02-11: rt AT_USER AT_USER AT_USER AT_USER topline data #asco possible buyout of $nwbo by $bmy $mrk $azn $gild $celg ht¡­|AT_USER we like $bmy|rt AT_USER AT_USER AT_USER AT_USER topline data #asco possible bu
2017-02-12: if $ibb can start moving, $gild $bmy (beaten names, which have offered fake bounce in the last few months )are on radar|rt AT_USER pharma stocks getting clobbered.. great buying opportunity for the lo
2017-02-13: #bristolmyerssquibb better buy: exelixis, inc. vs. bristol-myers squibb. read more:  $bmy|#bristolmyerssquibb better buy: exelixis, inc. vs. bristol-myers squibb. read more:  $bmy|need help finding mo
2017-02-14: $bmy  apparently the bear pattern is not confirmed. prices continue to rise. |nice #options swing j_dav! 200%+ on $bmy calls  #yachtclub #tradesocially |rt AT_USER streetinsider- $bmy is in play, $rog
2017-02-15: $bmy - buy signal at 53.71 on feb 14, 17 by  trading robot#stockstowatch #stockmarket #trading #trade #investing|rt AT_USER despite setbacks, $bmy remains confident in immuno-oncology |thursday: $shld
2017-02-16: swing trade $bmy |valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |any gypsy whispers out there on $bmy ?|#bristolmyerssquibb deut
Answer:
Rise